Acambis plc (“Acambis”) (LSE: ACM, NASDAQ: ACAM) announces that, following completion of the evidentiary hearing at the International Trade Commission (“ITC”) on the dispute between Acambis and Bavarian Nordic A/S (“BN”) relating to BN’s patents related to Modified Vaccinia Ankara, transcripts of the public sections of the hearing are now available.
